These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24114660)

  • 1. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.
    Antonio RC; Ceron CS; Rizzi E; Coelho EB; Tanus-Santos JE; Gerlach RF
    Mol Cell Biochem; 2014 Jan; 386(1-2):99-105. PubMed ID: 24114660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
    Mattos BR; Bonacio GF; Vitorino TR; Garcia VT; Amaral JH; Dellalibera-Joviliano R; Franca SC; Tanus-Santos JE; Rizzi E
    Biochem Pharmacol; 2020 Oct; 180():114121. PubMed ID: 32592722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension.
    Guimaraes DA; Rizzi E; Ceron CS; Oliveira AM; Oliveira DM; Castro MM; Tirapelli CR; Gerlach RF; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2011 May; 108(5):318-25. PubMed ID: 21176109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Marçal DM; Rizzi E; Martins-Oliveira A; Ceron CS; Guimaraes DA; Gerlach RF; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):35-44. PubMed ID: 21058008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
    Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat.
    Wu KI; Schmid-Schönbein GW
    Hypertension; 2011 Feb; 57(2):261-8. PubMed ID: 21220710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
    Castro MM; Rizzi E; Ceron CS; Guimaraes DA; Rodrigues GJ; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Nitric Oxide; 2012 Mar; 26(3):162-8. PubMed ID: 22327038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects.
    Rizzi E; Amaral JH; Guimarães DA; Conde-Tella SO; Pinheiro LC; Gerlach RF; Castro MM; Tanus-Santos JE
    Free Radic Biol Med; 2019 Jan; 130():234-243. PubMed ID: 30399409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats.
    Zeng S; Zhou X; Tu Y; Yao M; Han ZQ; Gao F; Li YM
    Clin Exp Hypertens; 2011; 33(5):316-24. PubMed ID: 21649529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction.
    Tran ED; DeLano FA; Schmid-Schönbein GW
    J Vasc Res; 2010; 47(5):423-31. PubMed ID: 20145415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloproteinase Inhibition Protects against Reductions in Circulating Adrenomedullin during Lead-induced Acute Hypertension.
    Nascimento RA; Mendes G; Possomato-Vieira JS; Gonçalves-Rizzi VH; Kushima H; Delella FK; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):508-15. PubMed ID: 25308714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
    Pereira SC; Parente JM; Belo VA; Mendes AS; Gonzaga NA; do Vale GT; Ceron CS; Tanus-Santos JE; Tirapelli CR; Castro MM
    Atherosclerosis; 2018 Mar; 270():146-153. PubMed ID: 29425960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
    Castro MM; Rizzi E; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Matrix Biol; 2010 Apr; 29(3):194-201. PubMed ID: 19969080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
    Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes.
    Rizzi E; Castro MM; Ceron CS; Neto-Neves EM; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Int J Cardiol; 2013 Apr; 165(1):165-73. PubMed ID: 21917342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
    Blascke de Mello MM; Parente JM; Schulz R; Castro MM
    Vascul Pharmacol; 2019 May; 116():36-44. PubMed ID: 30339939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.